Search Results - "Dahmen, Raphael"

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF by Bode, David, Semmler, Lukas, Wakula, Paulina, Hegemann, Niklas, Primessnig, Uwe, Beindorff, Nicola, Powell, David, Dahmen, Raphael, Ruetten, Hartmut, Oeing, Christian, Alogna, Alessio, Messroghli, Daniel, Pieske, Burkert M, Heinzel, Frank R, Hohendanner, Felix

“…Sodium-glucose linked transporter type 2 (SGLT-2) inhibition has been shown to reduce cardiovascular mortality in heart failure independently of glycemic…”
Get full text

Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study by Posch, Maximilian G., Walther, Niklas, Ferrannini, Ele, Powell, David R., Banks, Phillip, Wason, Suman, Dahmen, Raphael

“…OBJECTIVE Inhibiting sodium–glucose cotransporters (SGLTs) improves glycemic and cardiovascular outcomes in patients with type 2 diabetes (T2D). We…”
Get full text

Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes by BOLLI, Geremia B, HAHN, Annke D, SCHMIDT, Ronald, EISENBLAETTER, Tanja, DAHMEN, Raphael, HEISE, Tim, BECKER, Reinhard H. A

“…In vivo, after subcutaneous injection, insulin glargine (21(A)-Gly-31(B)-Arg-32(B)-Arg-human insulin) is enzymatically processed into 21(A)-Gly-human insulin…”
Get full text

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator by Visentin, Roberto, Giegerich, Clemens, Jäger, Robert, Dahmen, Raphael, Boss, Anders, Grant, Marshall, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas

“…Technosphere(®) insulin (TI), an inhaled human insulin with a fast onset of action, provides a novel option for the control of prandial glucose. We used the…”
Get more information

Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes by Pohlmeier, Harald, Berard, Lori, Brulle-Wohlhueter, Claire, Wu, Junlong, Dahmen, Raphael, Nowotny, Irene, Klonoff, David

“…Background: Insulin glargine 300 U/mL (Gla-300) contains the same active ingredient as glargine 100 U/mL (Gla-100), and provides the same number of units in…”
Get full text

New Insulin Glargine 300 Units·mL^sup-1^ Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units·mL^sup -1 by Becker, Reinhard HA, Dahmen, Raphael, Bergmann, Karin, Lehmann, Anne, Jax, Thomas, Heise, Tim

“…To characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of a new insulin glargine comprising 300 units...mL... (Gla-300), compared with insulin…”
Get full text

New insulin glargine 300 Units · mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units · mL-1 by Becker, Reinhard H A, Dahmen, Raphael, Bergmann, Karin, Lehmann, Anne, Jax, Thomas, Heise, Tim

“…To characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of a new insulin glargine comprising 300 units · mL(-1) (Gla-300), compared with insulin…”
Get full text